Navigation Links
Uterine Fibroid Patient Featured on CBS Evening News Has Become an Advocate for MR-Guided Focused Ultrasound
Date:6/22/2011

CHARLOTTESVILLE, Va., June 22, 2011 /PRNewswire/ -- On June 12, 2011, viewers of the CBS Evening News learned about Stephanie Small's gripping story. Suffering from a large uterine fibroid, the 27-year-old was treated last December as part of a MR-guided focused ultrasound clinical trial at the University of Virginia in Charlottesville.

Small says her focused ultrasound treatment changed her life. She experienced symptom relief within a few days and reports that her quality of life has steadily and significantly improved.  "I think focused ultrasound surgery is amazing, and I believe that fears of incisions, scaring, complications and long painful recovery times are now concerns of the past with this new technology," she says.

Small's journey unfolded over many months, from the time she received her diagnosis and was advised to have a myomectomy. Fearful of the risks associated with that treatment, she began searching for other options. Surfing the web for information, she discovered the websites for the Focused Ultrasound Surgery Foundation and its patient support organization, Fibroid Relief. What she learned there proved to be invaluable and convinced her to opt for MR-guided focused ultrasound treatment. She made arrangements to undergo the noninvasive outpatient procedure at a center near her home in eastern Pennsylvania.

However, a major stumbling block quickly surfaced: Small's health insurer refused to cover her focused ultrasound treatment. Determined to proceed, she downloaded the Reimbursement Resource Toolkit from the Fibroid Relief website. A popular resource that has been downloaded 1350 times since its August 2010 debut, the toolkit contains sample letters and tips for appealing a health plan denial.

Faced with steadily increasing pain and disability, Small opted to participate in the UVA study rather tha
'/>"/>

SOURCE Focused Ultrasound Surgery Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Smith & Nephews TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
2. Elbit Imaging Announces InSightecs First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
3. First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
4. Society of Interventional Radiology Applauds Reports Uterine Fibroid Embolization Recommendations
5. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
6. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
7. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
8. Alternative Surgeries for California Women Suffering From Fibroids
9. Minimally Invasive Device Approved to Treat Liver Cancer, Fibroids, Tumors, and Bleeding
10. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
11. New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... MOUNTAIN VIEW, Calif. , Oct. 20, 2014 /PRNewswire/ ... field of interventional pulmonology, today announced completion of enrollment ... schedule.  The RENEW Clinical Study is the FDA-approved IDE ... treatment for severe emphysema. It was anticipated ... US in February 2013, would take until the end ...
(Date:10/20/2014)... 20, 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Surgeons Annual Meeting that they have joined forces ... The collaboration is the first of its kind ... patient outcomes. NICO,s BrainPath® interventional access technology and ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... June 4 After three long years of ... of Phoebe Sumter Medical Center welcomed the arrival of a ... Siemens Healthcare. The new MRI scanner premiered today at the ... destroyed the hospital in 2007. State and local political dignitaries ...
... Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary ... and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... version of Pfizer,s Neurontin® Tablets for the treatment of postherpetic neuralgia, ... Pharmaceuticals Inc. , , ...
Cached Medicine Technology:Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 2Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 3Mylan Receives Approval for Generic Version of Neurontin® Tablets 2
(Date:10/22/2014)... For Dr. Iris Hunter, a job is more than just ... life’s mission. Her extensive experience in the nonprofit sector, coupled ... make it clear that Hunter’s mission is to serve others. ... a difference in the lives of others,” Hunter said. “Additionally, ... I felt ready to start on this journey as a ...
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the ... has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is ... around the world. , “iPower is one of the ... providing various kinds of useful products for new and ... excellent customer service and a number of features which ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2
... Even while their blood pressures are still normal, overweight ... known to increase pressures as well as early signs ... Georgia researchers looking at 126 healthy 15- to17-year-olds in ... highest among the overweight males. Early intervention could help ...
... form of childhood epilepsy called infantile spasms have developed ... closely resembling those occurring in patients with infantile seizures. ... scientists to test treatments that may benefit children. ... a seizure. Many of them go on to have ...
... Annuity offers a simplified solution to generating lifetime income ... , - Simple A share structure , , ... of a new retirement income product designed to bring the ... the reach of traditional variable annuities. The new product, John ...
... Products Earn Mention in New Stop Growing Older ... Grow ... his just released book "Stop Growing Older ... Grow Younger," ... the multi-billion-dollar anti-aging industry. Throughout the pages of this resource, ... advocating instead an all-natural approach to slowing down the aging ...
... 1 Abbott will present at the Goldman Sachs 30th ... D. White, chairman and chief executive officer, and Thomas C. ... make a presentation on the company at 9:20 a.m. Central ... presentation will be accessible through Abbott,s Investor Relations Web site ...
... standard chemotherapy, an international Phase III trial has shown ... for patients with advanced non-small cell lung cancer, according ... Anderson Cancer Center. The findings, presented today at ... the first clinical benefit of a small molecule targeted ...
Cached Medicine News:Health News:Overweight male teens with normal blood pressures showing signs of heart damage 2Health News:Overweight male teens with normal blood pressures showing signs of heart damage 3Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 2Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 3Health News:John Hancock Launches New Retirement Income Solution 2Health News:John Hancock Launches New Retirement Income Solution 3Health News:John Hancock Launches New Retirement Income Solution 4Health News:John Hancock Launches New Retirement Income Solution 5Health News:Explorer's Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 3
These are simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in healthcare facilities....
... E*Kits® can be a valuable tool in ... the items necessary for a procedure are ... and continuum of care are easier to ... in sequence of use, allowing the clinician ...
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
These simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in hospitals....
Medicine Products: